| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 209 | 2003 | Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer | BUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, Jan | Journal Contribution | A1 |
| 210 | 2003 | Validation of a longitudinally measured surrogate for a time-to-event endpoint | RENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc | Journal Contribution | A1 |
| 211 | 2003 | Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer | Vinh-Hung, V.; BURZYKOWSKI, Tomasz; Cserni, G.; Voordeckers, M.; Van de Steene, J.; Storme, G. | Journal Contribution | A1 |
| 212 | 2003 | Effect of the number of uninvolved nodes on survival in early breast cancer | Vinh-Hung, Vincent; Cserni, Gabor; BURZYKOWSKI, Tomasz; Van de Steene, Jan; Voordeckers, Mia; Storme, Guy | Journal Contribution | A1 |
| 213 | 2002 | Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? | Cserni, G.; Vinh-Hung, V.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 214 | 2002 | Post-surgery radiation in early breast cancer: survival analysis of registry data | Vinh-Hung, Vincent; BURZYKOWSKI, Tomasz; Van de Steene, Jan; Storme, Guy; Soete, Guy | Journal Contribution | A1 |
| 215 | 2002 | Methodology for the validation of surrogate endpoints in multiple randomized experiments | BURZYKOWSKI, Tomasz | Proceedings Paper | C1 |
| 216 | 2002 | A version of the EM algorithm for proportional hazards models with random effects | CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz | Journal Contribution | A2 |
| 217 | 2002 | Bayesian models in the evaluation of surrogate endpoints | TORRES BARBOSA, Franz; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BURZYKOWSKI, Tomasz; GEYS, Helena; Allende, S.; MOLENBERGHS, Geert | Proceedings Paper | C2 |
| 218 | 2002 | Statistical challenges in the evaluation of surrogate endpoints in randomized trials | MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 219 | 2002 | Challenges in the methodology for the validation of surrogate endpoints in randomized trials | MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz | Proceedings Paper | C2 |
| 220 | 2002 | Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomes | RENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 221 | 2001 | Validation of surrogate endpoints from multiple randomized clinical trials with a failure-time true endpoint | BURZYKOWSKI, Tomasz | Theses and Dissertations | T1 |
| 222 | 2001 | Strong association between p53 protein accumulation, serum antibodies and gene mutation in non-small cell lung cancer | Niklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Laudanski, J.; Niklinski, J. | Journal Contribution | A1 |
| 223 | 2001 | Methodology for the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 224 | 2001 | Methodology of the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 225 | 2001 | Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis | Niklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Niklinski, Jacek | Journal Contribution | A1 |
| 226 | 2001 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Journal Contribution | A1 |
| 227 | 2001 | Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer | BUYSE, Marc; Thirion, Pierre; Carlson, Robert; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 228 | 2001 | Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer | Laudanski, J.; Niklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Niklinski, J. | Journal Contribution | A1 |
| 229 | 2000 | P53 gene mutation and protein expression in operable non-small cell lung cancer in Poland | Niklinska, W.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Rusin, M. R.; Furman, M.; Laudanski, J.; Chyczewska, E.; Sulik, M.; Niklinski, Jacek | Journal Contribution | A1 |
| 230 | 2000 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Proceedings Paper | C1 |
| 231 | 2000 | Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis | BUYSE, Marc; Thirion, Pierre; Carlson, Robert W.; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 232 | 2000 | Statistical validation of surrogate endpoints: problems and proposals | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 233 | 2000 | Corrigendum to "The validation of surrogate endpoints in randomized experiments" | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 234 | 2000 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 235 | 1999 | The effect of long-term water storage on the tensile strength of orthodontic brackets bonded with resin-reinforced glass-ionomer cements | Czochrowska, E.; BURZYKOWSKI, Tomasz; Buyukyilmaz, T.; Ogaard, B. | Journal Contribution | |
| 236 | 1999 | Low-dose Glucose-Insulin-Potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial | Ceremuzynski, L.; Budaj, A.; Czepiel, A.; BURZYKOWSKI, Tomasz; Achremczyk, P.; Smielak-Korombel, W.; Maciejewicz, J.; Dziubinska, J.; Nartowicz, E.; Kawka-Urbanek, T.; Piotrowski, W.; Hanzlik, J.; Cieslinski, A.; Kawecka-Jaszcz, K.; Gessek, J.; Wrabec, K. | Journal Contribution | |
| 237 | 1999 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Proceedings Paper | |
| 238 | 1999 | Analysis of incomplete public health data | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; MICHIELS, Bart; Kenward, Michael G. | Journal Contribution | |
| 239 | 1999 | Missing Data in the Health Interview Survey 1997 in Belgium | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Tafforeau, Jean; Van Oyen, Herman; Demarest, S.; Bellamammer, L. | Journal Contribution | |
| 240 | 1998 | Quasi-optimal selection of stratification variables in representative studies based on an example in agriculture | BURZYKOWSKI, Tomasz | Journal Contribution | |
| 241 | 1998 | Prognostic value of serum p53 antibodies in patients with resected non-small lung cancer | Laudanski, J.; BURZYKOWSKI, Tomasz; Niklinska, W.; Chyczewski, L.; Furman, M.; Niklinski, Jacek | Journal Contribution | |
| 242 | 1998 | Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer | Niklinski, Jacek; BURZYKOWSKI, Tomasz; Niklinska, W.; Laudanski, J.; Chyczewski, L.; Rapellino, M.; Furman, M. | Journal Contribution | |
| 243 | 1997 | Changes of thyroid cancer incidence in 1986-1994 in Poland | Chmielarczyk, Wiktor; BURZYKOWSKI, Tomasz; Wronkowski, Zbigniew; Zwierko, Maria | Journal Contribution | |
| 244 | 1996 | Some issues related to organization of clinical trials | BURZYKOWSKI, Tomasz | Book Section | |
| 245 | 1996 | Preoperative CYFRA 21-1 level as a prognostic factor in resected primary squamous cell lung cancer | Niklinski, Jacek; Furman, M.; BURZYKOWSKI, Tomasz; Chyczewski, L.; Laudanski, J.; Chyczewska, E.; Rapellino, M. | Journal Contribution | |
| 246 | 1996 | Basic problems and methods of organization of clinical trials | BURZYKOWSKI, Tomasz | Journal Contribution | |
| 247 | 1994 | Prognostic value of the Duke, Astler-Coller and Jass classification and the type of CEA localization in rectal carcinoma - a multivariate analysis | Nasierowska-Guttmejer, Anna; Roszkowska-Purska, Katarzyna; Maryniak, R.; BURZYKOWSKI, Tomasz; Nowacki, M. | Journal Contribution | |
| 248 | 1994 | Meta-analysis: A useful tool in scientific work of an oncologist | BURZYKOWSKI, Tomasz; Ruka, W. | Journal Contribution | |
| 249 | 1993 | Prognostic factors in radiotherapy of oropharyngeal cancer | Szutkowski, M.; Wasilewski, M.; BURZYKOWSKI, Tomasz | Journal Contribution | |
| 250 | 1993 | A voice in discussion on A. Hliniak's article on 'Preparation and presentation of analysis of clinical data' | BURZYKOWSKI, Tomasz | Journal Contribution | |